Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 474

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)

Open access
Hoffmann, Udo, Ferencik, Maros, Udelson, James E., Picard, Michael H., Truong, Quynh A., Patel, Manesh R., Huang, Megan, Pencina, Michael, Mark, Daniel B., Heitner, John F., Fordyce, Christopher B., Pellikka, Patricia A., Tardif, Jean-Claude, Budoff, Matthew, Nahhas, George, Chow, Benjamin, Kosinski, Andrzej S., Lee, Kerry L., Douglas, Pamela S.·2017·Circulation

Abstract

Background: Optimal management of patients with stable chest pain relies on the prognostic information provided by noninvasive cardiovascular testing, but there are limited data from randomized trials comparing anatomic with functional testing. Methods: In the PROMISE trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain), patients with stable chest pain and intermediate pretest probability for obstructive coronary artery disease (CAD) were randomly assigned to functional testing (exercise electrocardiography, nuclear stress, or stress echocardiography) or coronary computed tomography angiography (CTA). Site-based diagnostic test reports were classified as normal or mildly, moderately, or severely abnormal. The primary end point was death, myocardial infarction, or unstable angina hospitalizations over a median follow-up of 26.1 months. Results: Both the prevalence of normal test results and incidence rate of events in these patients were significantly lower among 4500 patients randomly assigned to CTA in comparison with 4602 patients randomly assigned to functional testing (33.4% versus 78.0%, and 0.9% versus 2.1%, respectively; both P <0.001). In CTA, 54.0% of events (n=74/137) occurred in patients with nonobstructive CAD (1%–69% stenosis). Prevalence of obstructive CAD and myocardial ischemia was low (11.9% versus 12.7%, respectively), with both findings having similar prognostic value (hazard ratio, 3.74; 95% confidence interval [CI], 2.60–5.39; and 3.47; 95% CI, 2.42–4.99). When test findings were stratified as mildly, moderately, or severely abnormal, hazard ratios for events in comparison with normal tests increased proportionally for CTA (2.94, 7.67, 10.13; all P <0.001) but not for corresponding functional testing categories (0.94 [ P =0.87], 2.65 [ P =0.001], 3.88 [ P <0.001]). The discriminatory ability of CTA in predicting events was significantly better than functional testing (c-index, 0.72; 95% CI, 0.68–0.76 versus 0.64; 95% CI, 0.59–0.69; P =0.04). If 2714 patients with at least an intermediate Framingham Risk Score (>10%) who had a normal functional test were reclassified as being mildly abnormal, the discriminatory capacity improved to 0.69 (95% CI, 0.64–0.74). Conclusions: Coronary CTA, by identifying patients at risk because of nonobstructive CAD, provides better prognostic information than functional testing in contemporary patients who have stable chest pain with a low burden of obstructive CAD, myocardial ischemia, and events. Clinical Trial Registration: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01174550.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.116.024360

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 474

Metadata

Authors
Hoffmann, U., Ferencik, M., Udelson, J. E., Picard, M. H., Truong, Q. A., Patel, M. R., Huang, M., Pencina, M., Mark, D. B., Heitner, J. F., Fordyce, C. B., Pellikka, P. A., Tardif, J.-C., Budoff, M., Nahhas, G., Chow, B., Kosinski, A. S., Lee, K. L., & Douglas, P. S.
Venue
Circulation
Published
2017-06-13
Volume
135
Issue
24
Pages
2320-2332
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2625392805
Cited by
474
References
43
FWCI
30.48
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). https://app.cochat.ai/papers/10.1161/circulationaha.116.024360
The paper
Hoffmann, U., Ferencik, M., Udelson, J. E., Picard, M. H., Truong, Q. A., Patel, M. R., Huang, M., Pencina, M., Mark, D. B., Heitner, J. F., Fordyce, C. B., Pellikka, P. A., Tardif, J.-C., Budoff, M., Nahhas, G., Chow, B., Kosinski, A. S., Lee, K. L., & Douglas, P. S. (2017). Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation. https://doi.org/10.1161/circulationaha.116.024360

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.